CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
Presented by CURE®, a collection of resources that provide information and support for patients with squamous cell carcinoma and the professionals who treat them.
November 15th 2018
The combination use of two immunotherapy agents in the first-line setting helped patients with advanced melanoma live longer compared with treatment with either drug alone.
October 22nd 2018
To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.
October 20th 2018
A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.
October 17th 2018
As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.
October 15th 2018
The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.
October 13th 2018
Lynn Schuchter, M.D., discussed immunotherapy and BRAF/MEK inhibition at the Melanoma Action Coalition’s Fall Conference.
September 16th 2018
Substitute thinking "life management" instead of "time management."
September 11th 2018
Two-time cancer survivor encourages fellow survivors to develop resilience to cope with cancer.
September 7th 2018
I felt like cancer had forced me to do other "uncomfortable" things instead of the bucket list I had chosen.
September 4th 2018
The Food and Drug Administration (FDA) granted priority review to a new supplemental biologics license application for Keytruda (pembrolizumab) to treat adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to Merck, the agent’s manufacturer.
August 16th 2018
Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.
August 15th 2018
Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.
August 7th 2018
Research continues to drive the oncology field.
Patients who receive anti-PD-1 therapies may experience delayed cutaneous side effects like lesions, eczema or psoriasis, even after treatment has ended.
July 30th 2018
Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.
July 28th 2018
Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.
July 18th 2018
Understanding how melanoma spreads can lead to better outcomes. That's what researchers at UCSF aimed to do.
July 13th 2018
July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.
July 4th 2018
While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.
June 27th 2018
The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.
June 25th 2018
The FDA has accepted a supplemental biologics license application (sBLA) for the use of Keytruda (pembrolizumab) as an adjuvant treatment for patients with resected, high-risk stage 3 melanoma, according to Merck (MSD), the manufacturer of the PD-1 inhibitor.
June 22nd 2018
In melanoma, combining two immunotherapies may lower costs and improve quality of life.
June 21st 2018
Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.
June 20th 2018
Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.
June 19th 2018
Checkpoint inhibitors can be extremely effective for the right patients, but identifying who will benefit remains an imprecise science.
A new expert guideline for managing immunotherapy’s side effects has been released.
June 15th 2018
Study findings published in the Journal of the American Academy of Dermatology showed that once-daily aspirin use can increase the risk of melanoma in men — nearly double that of men who do not use aspirin each day.
June 14th 2018
Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Age shouldn't be a determining factor in giving a patient with melanoma immunotherapy. In fact, one study found that older patients actually do better on checkpoint blockades.
June 11th 2018
Recognize birthdays, but most importantly, keep hope, says a breast cancer and melanoma survivor.
Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years
Oncologists Have Feelings Too: Navigating the Patient Physician Relationship
Debunking Myths of Clinical Trials for Cancer
Highlighting Geographic, Economic Disparities in Cancer Care